Brief: Eurocine Vaccines Q2 Operating Loss Narrows To SEK 2.7 Million
Feb 27 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* Q2 OPERATING LOSS SEK 2.7 MILLION VERSUS LOSS SEK 9.4
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5j8CS1
Further company coverage: EUCI.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate